查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1618510

白血球去除術市場：按類型、應用和最終用戶分類 - 全球預測 2025-2030

Leukapheresis Market by Type (Leukapheresis Devices, Leukapheresis Disposables), Application (Research Applications, Therapeutic Applications), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年白血球去除療法市場價值為5,621萬美元，預計到2024年將達到6,162萬美元，複合年成長率為9.71%，預計到2030年將達到10,758萬美元。

白血球分離術是一種從血液中分離白血球的特殊程序，用於治療和治療，特別是收集細胞以治療白血病和淋巴瘤等疾病，或在 CAR T 細胞療法等先進治療中發揮重要作用。 。這種需求主要源於對準確的血液成分分離的需求，既可以用於即時治療性介入，也可以用於在新興的細胞研究領域中培養細胞。白血球去除術應用涵蓋臨床、商業和研究領域，最終用途為醫院、研究機構和生物技術公司。市場成長是由血液相關疾病的增加、細胞治療方法的進步以及對個人化醫療的日益關注所推動的。新的商機在於改進單採技術並利用人工智慧整合進行流程最佳化。專注於細胞治療的生物技術新興企業的激增進一步凸顯了潛在的市場擴張。然而，挑戰包括程序成本高、監管複雜性以及發展中地區的意識低。創新機會存在於白血球分離設備的自動化和提高效率、改善捐贈者安全通訊協定以及降低營運成本。該市場是動態的，其特點是技術的快速進步以及醫療保健提供者和生物技術公司之間的合作。儘管面臨挑戰，但擴大單採技術範圍和效率的廣泛研發投資和跨部門夥伴關係可以推動市場成長。公司可以透過資料分析和機器學習創新來利用不斷發展的精準醫療領域，以完善患者選擇策略並個人化治療結果。未來的研究可以專注於具有成本效益和可擴展的技術以及更廣泛的教育舉措，以提高滲透率較低的市場的意識。隨著市場應對這些複雜性，新興市場的策略定位、技術改進以及遵守不斷變化的監管標準對於持續成長至關重要。

主要市場統計
基準年[2023] 5621萬美元
預計年份 [2024] 6162萬美元
預測年份 [2030] 10758萬美元
複合年成長率（%） 9.71%

市場動態：揭示快速發展的白血球分離術市場的關鍵市場洞察

供需的動態交互作用正在改變白血球分離術市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 擴大癌症治療的應用
    • 臨床研究對白血球分離術的需求
    • 加大捐血力度
  • 市場限制因素
    • 治療費用高
  • 市場機會
    • 研發活動的重點與投資
    • CAR 或過繼性細胞療法白血球去除術
  • 市場問題
    • 與白血球分離術相關的潛在問題，包括不適、發紅和瘀傷

波特的五力：駕馭白血球分離術市場的策略工具

波特的五力架構是了解白血球分離術市場競爭格局的關鍵工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點，避免潛在的挑戰，確保更強大的市場地位。

PESTLE分析：了解白血球分離術市場的外部影響

外部宏觀環境因素在塑造白血球分離市場的績效動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析：了解白血球分離術市場的競爭格局

對白血球去除療法市場的詳細市場佔有率分析可以對供應商的業績進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣：白血球去除術市場供應商的績效評估

FPNV 定位矩陣是評估白血球分離市場供應商的關鍵工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議：繪製白血球分離術市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，白血球分離術市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1.市場滲透率：對當前市場環境的詳細審查，主要企業的廣泛資料，評估他們在市場中的影響力和整體影響力。

2. 市場開發：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、未開發地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 擴大癌症治療的應用
      • 臨床研究對白血球分離術的需求
      • 擴大捐血活動
    • 抑制因素
      • 手續成本高
    • 機會
      • 研發活動的重點與投資
      • CAR 或過繼性細胞療法白血球去除術
    • 任務
      • 與白血球分離術相關的潛在問題，例如不適、發紅和瘀傷
  • 市場區隔分析
    • 類型：增加使用白血球分離裝置有效分離白血球
    • 用途：增加白血球去除術在治療上的應用，以改善患者的治療效果
    • 最終用戶：血液成分供應商和血液中心對白血球分離設備的使用激增
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章白血球去除術市場：依類型

  • 介紹
  • 裝置
    • 離心分離機
    • 膜分離設備
  • 消耗品

第7章白血球去除術市場：依應用分類

  • 介紹
  • 研究用途
  • 治療用途

第8章白血球去除術市場：依最終用戶分類

  • 介紹
  • 學術研究所
  • 血液成分供應商和血液中心
  • 合約研究組織
  • 醫院及輸血中心
  • 製藥和生物技術公司

第9章北美和南美白血球去除治療市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太白血球分離市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲的白血球去除術市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • SCTbio 與 Cyto-Care 合作改善細胞治療的冷凍保存
    • Akadeum 利用正選推出 T 細胞活化和擴增，擴大了 Leukopak 細胞分離產品線
    • Fresenius Kabi 推出 Amicus體外光化學療法通訊協定的單針選項
  • 戰略分析和建議

公司名單

  • Allcells, LLC
  • Asahi Kasei Corporation
  • Beijing Zksk Technology Co. Ltd.
  • Bioivt
  • Caltag Medsystems Limited
  • Charles River Laboratories International, Inc.
  • Discovery Life Sciences
  • Fresenius Se & Co. Kgaa
  • Guangzhou Daji Medical Science and Technology Co. Ltd.
  • Haemonetics Corporation
  • Intelligent Tissue Group
  • Lonza Group Ag
  • Macopharma Sa
  • Medica Spa.
  • Miltenyi BIoTec
  • Precision for Medicine, Inc.
  • Puriblood Medical Co. Ltd.
  • Stemexpress, LLC
  • Terumo BCT
  • Zenbio, Inc.
Product Code: MRR-FD3F12D52871

The Leukapheresis Market was valued at USD 56.21 million in 2023, expected to reach USD 61.62 million in 2024, and is projected to grow at a CAGR of 9.71%, to USD 107.58 million by 2030.

Leukapheresis, a specialized procedure to separate leukocytes (white blood cells) from the blood, plays a critical role in therapeutic and research settings, particularly in treating conditions like leukemia and lymphoma and for harvesting cells for advanced therapies like CAR T-cell therapies. Its necessity arises primarily from the need for precise blood component separation for both immediate therapeutic interventions and the cultivation of cells in burgeoning cell-based research. The application of leukapheresis spans clinical, commercial, and research domains, with end-use in hospitals, research institutes, and biotechnology companies. Market growth is fueled by rising incidences of blood-related disorders, advancements in cell-based therapies, and an increasing focus on personalized medicine. Emerging opportunities lie in leveraging improvements in apheresis technologies and the integration of AI for process optimization. The proliferation of biotech startups focusing on cell therapy further underscores potential market expansion. However, challenges include high procedure costs, regulatory complexities, and limited awareness in developing regions. Innovation opportunities exist in enhancing automation and efficiency of leukapheresis devices, improving donor safety protocols, and reducing operational costs. The market is dynamic, characterized by rapid technological advancements and collaboration between healthcare providers and biotechnology firms. Despite the challenges, extensive R&D investment in expanding the scope and efficiency of apheresis technologies and cross-sector partnerships can foster market growth. Companies may capitalize on the developing precision medicine sector by innovating in data analytics and machine learning to refine patient-selection strategies and personalize treatment outcomes. Future research could focus on cost-effective, scalable leukapheresis techniques and broader educational initiatives to heighten awareness in underpenetrated markets. As the market navigates these complexities, strategic positioning in emerging economies, technological enhancements, and compliance with evolving regulatory standards will be crucial for sustained growth.

KEY MARKET STATISTICS
Base Year [2023] USD 56.21 million
Estimated Year [2024] USD 61.62 million
Forecast Year [2030] USD 107.58 million
CAGR (%) 9.71%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Leukapheresis Market

The Leukapheresis Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing application in cancer therapy
    • Demand for leukapheresis in clinical research
    • Growth in initiatives for blood donations
  • Market Restraints
    • High cost of procedure
  • Market Opportunities
    • Focus and investment in R&D activities
    • Leukapheresis for CAR or Adoptive Cell Therapy
  • Market Challenges
    • Potential issues related to leukapheresis including discomfort, redness, and bruising

Porter's Five Forces: A Strategic Tool for Navigating the Leukapheresis Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Leukapheresis Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Leukapheresis Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Leukapheresis Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Leukapheresis Market

A detailed market share analysis in the Leukapheresis Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Leukapheresis Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Leukapheresis Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Leukapheresis Market

A strategic analysis of the Leukapheresis Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Leukapheresis Market, highlighting leading vendors and their innovative profiles. These include Allcells, LLC, Asahi Kasei Corporation, Beijing Zksk Technology Co. Ltd., Bioivt, Caltag Medsystems Limited, Charles River Laboratories International, Inc., Discovery Life Sciences, Fresenius Se & Co. Kgaa, Guangzhou Daji Medical Science and Technology Co. Ltd., Haemonetics Corporation, Intelligent Tissue Group, Lonza Group Ag, Macopharma Sa, Medica Spa., Miltenyi Biotec, Precision for Medicine, Inc., Puriblood Medical Co. Ltd., Stemexpress, LLC, Terumo BCT, and Zenbio, Inc..

Market Segmentation & Coverage

This research report categorizes the Leukapheresis Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Leukapheresis Devices and Leukapheresis Disposables. The Leukapheresis Devices is further studied across Centrifugal Devices and Membrane Separators.
  • Based on Application, market is studied across Research Applications and Therapeutic Applications.
  • Based on End-User, market is studied across Academic & Research Institutes, Blood Component Providers & Blood Centers, Contract Research Organizations, Hospitals & Transfusion Centers, and Pharmaceutical & Biotechnology Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing application in cancer therapy
      • 5.1.1.2. Demand for leukapheresis in clinical research
      • 5.1.1.3. Growth in initiatives for blood donations
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of procedure
    • 5.1.3. Opportunities
      • 5.1.3.1. Focus and investment in R&D activities
      • 5.1.3.2. Leukapheresis for CAR or Adoptive Cell Therapy
    • 5.1.4. Challenges
      • 5.1.4.1. Potential issues related to leukapheresis including discomfort, redness, and bruising
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Increasing use of leukapheresis devices for efficient separation of white blood cells
    • 5.2.2. Application: Rising application of leukapheresis in therapeutics for improved patient outcome
    • 5.2.3. End-User: Proliferating use of leukapheresis devices by blood component providers & blood centers
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Leukapheresis Market, by Type

  • 6.1. Introduction
  • 6.2. Leukapheresis Devices
    • 6.2.1. Centrifugal Devices
    • 6.2.2. Membrane Separators
  • 6.3. Leukapheresis Disposables

7. Leukapheresis Market, by Application

  • 7.1. Introduction
  • 7.2. Research Applications
  • 7.3. Therapeutic Applications

8. Leukapheresis Market, by End-User

  • 8.1. Introduction
  • 8.2. Academic & Research Institutes
  • 8.3. Blood Component Providers & Blood Centers
  • 8.4. Contract Research Organizations
  • 8.5. Hospitals & Transfusion Centers
  • 8.6. Pharmaceutical & Biotechnology Companies

9. Americas Leukapheresis Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Leukapheresis Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Leukapheresis Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. SCTbio Partners With Cyto-Care To Improve Cell Therapy Cryopreservation
    • 12.3.2. Akadeum Launches T Cell Activation and Expansion Using Positive Selection and Expands Leukopak Cell Isolation Product Lines
    • 12.3.3. Fresenius Kabi Launches Single-Needle Option for the Amicus Extracorporeal Photopheresis Protocol
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Allcells, LLC
  • 2. Asahi Kasei Corporation
  • 3. Beijing Zksk Technology Co. Ltd.
  • 4. Bioivt
  • 5. Caltag Medsystems Limited
  • 6. Charles River Laboratories International, Inc.
  • 7. Discovery Life Sciences
  • 8. Fresenius Se & Co. Kgaa
  • 9. Guangzhou Daji Medical Science and Technology Co. Ltd.
  • 10. Haemonetics Corporation
  • 11. Intelligent Tissue Group
  • 12. Lonza Group Ag
  • 13. Macopharma Sa
  • 14. Medica Spa.
  • 15. Miltenyi Biotec
  • 16. Precision for Medicine, Inc.
  • 17. Puriblood Medical Co. Ltd.
  • 18. Stemexpress, LLC
  • 19. Terumo BCT
  • 20. Zenbio, Inc.

LIST OF FIGURES

  • FIGURE 1. LEUKAPHERESIS MARKET RESEARCH PROCESS
  • FIGURE 2. LEUKAPHERESIS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL LEUKAPHERESIS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL LEUKAPHERESIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL LEUKAPHERESIS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL LEUKAPHERESIS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL LEUKAPHERESIS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL LEUKAPHERESIS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS LEUKAPHERESIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS LEUKAPHERESIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES LEUKAPHERESIS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES LEUKAPHERESIS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC LEUKAPHERESIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC LEUKAPHERESIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA LEUKAPHERESIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA LEUKAPHERESIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. LEUKAPHERESIS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. LEUKAPHERESIS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. LEUKAPHERESIS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL LEUKAPHERESIS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL LEUKAPHERESIS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL LEUKAPHERESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. LEUKAPHERESIS MARKET DYNAMICS
  • TABLE 7. GLOBAL LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL LEUKAPHERESIS MARKET SIZE, BY CENTRIFUGAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL LEUKAPHERESIS MARKET SIZE, BY MEMBRANE SEPARATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DISPOSABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL LEUKAPHERESIS MARKET SIZE, BY RESEARCH APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL LEUKAPHERESIS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL LEUKAPHERESIS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL LEUKAPHERESIS MARKET SIZE, BY BLOOD COMPONENT PROVIDERS & BLOOD CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL LEUKAPHERESIS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL LEUKAPHERESIS MARKET SIZE, BY HOSPITALS & TRANSFUSION CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL LEUKAPHERESIS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS LEUKAPHERESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES LEUKAPHERESIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC LEUKAPHERESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA LEUKAPHERESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM LEUKAPHERESIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM LEUKAPHERESIS MARKET SIZE, BY LEUKAPHERESIS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM LEUKAPHERESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM LEUKAPHERESIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 190. LEUKAPHERESIS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 191. LEUKAPHERESIS MARKET, FPNV POSITIONING MATRIX, 2023